Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06676618 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Effect of Multimodal Exercise Training in Patients With Multiple Sclerosis

Study acronym: PwMS
StatusRecruiting
PhaseNot applicable
Started2025-02-10
View on ClinicalTrials.gov ↗

Amendment history

2026-03-13
Not Yet Recruiting→Recruiting Study Status, Study Design, Arms and Interventions, Eligibility, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Primary completion date2026-12-01→2027-05-01
Completion date2027-04-01→2028-05-01
Start dateestimated 2024-12-01→confirmed 2025-02-10
Study sites1→2
2024-11-05
Study Status, Sponsor/Collaborators, Study Description, Arms and Interventions, Outcome Measures v1
Secondary endpoints7 entries, revised
6 Minute Walk Test (6MWT) (The change between the initial value and the value after 3 months will be evaluated).
Study description+2 characters
[...] to-face and TR on disease activity and functional status in peoplepatients with MS (PwMS). PwMS with an Expanded Disability Status Sca [...]
2024-11-05
Original filing
The study aims to examine the effects of multimodal exercise training including aerobic, strengthening and balance exercises via face-to-face and asynchronous video-based telerehabilitation on disease activity, disability level, aerobic capacity, physical activity level, balance, fatigue level and quality of life in individuals with multiple sclerosis. Therefore, this study consists of two hypotheses. Hypotheses: H0: Multimodal exercise training has no effect on disease activity and functional status in patients with multiple sclerosis H1: Multimodal exercise training has effects on disease activity and functional status in patients with multiple sclerosis
Trial Details
NCT Number NCT06676618
Lead Sponsor Istanbul University - Cerrahpasa
Conditions Multiple Sclerosis
Enrollment 40 participants
Start Date 2025-02-10
Primary Completion 2027-05-01 (estimated)
Study Completion 2028-05-01 (estimated)
Updated on ClinicalTrials.gov 2026-03-17